http://topics.cnn.com/topics/feeds/rss/Merck_Co_IncFind stories, videos, and photos about Merck & Co. Inc. from CNN.com.en-usCable News Network LP, LLLP.Sun, 08 Nov 2009 17:36:50 GMT5http://i.cdn.turner.com/cnn/.element/img/1.0/logo/cnn.logo.rss.gifhttp://topics.cnn.com/topics/feeds/rss/Merck_Co_Inc14433Find stories, videos, and photos about Merck & Co. Inc. from CNN.com.http://money.cnn.com/2009/03/09/news/companies/merck_schering_plough/index.htmhttp://money.cnn.com/2009/03/09/news/companies/merck_schering_plough/index.htmDrugmaker Merck & Co. announced Monday that it has agreed to acquire rival Schering-Plough Corp. in a deal worth $41.1 billion.Mon, 09 Mar 2009 16:47:00 EDThttp://money.cnn.com/2009/03/09/markets/stockswatch/index.htmhttp://money.cnn.com/2009/03/09/markets/stockswatch/index.htmStocks turned higher Monday morning as investors considered Merck's $41 billion purchase of Schering-Plough and opted to scoop up shares hit in the recent selloff.Mon, 09 Mar 2009 14:22:00 EDThttp://www.cnn.com/2008/HEALTH/conditions/10/09/gardasil.teenagers/index.html#cnnSTCTexthttp://www.cnn.com/2008/HEALTH/conditions/10/09/gardasil.teenagers/index.html#cnnSTCTextAbout one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday.Thu, 09 Oct 2008 20:10:00 EDThttp://www.time.com/time/business/article/0,8599,1823902,00.html?xid=feed-cnn-topicshttp://www.time.com/time/business/article/0,8599,1823902,00.html?xid=feed-cnn-topicsDrugmaker Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next monthThu, 17 Jul 2008 19:00:00 EDThttp://www.cnn.com/2008/HEALTH/conditions/07/07/cervical.cancer.vaccine/index.html#cnnSTCTexthttp://www.cnn.com/2008/HEALTH/conditions/07/07/cervical.cancer.vaccine/index.html#cnnSTCTextA vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.Mon, 07 Jul 2008 20:10:00 EDThttp://money.cnn.com/2008/04/29/markets/markets_newyork/index.htmhttp://money.cnn.com/2008/04/29/markets/markets_newyork/index.htmStocks ended mixed Tuesday for the second day in a row, after declining most of the session, following a troubling report on consumer confidence and some trepidation about what the Federal Reserve will decide at the conclusion of its two-day meeting that began this morning.Tue, 29 Apr 2008 20:58:00 EDThttp://money.cnn.com/2008/04/29/markets/stockswatch_ny/index.htmhttp://money.cnn.com/2008/04/29/markets/stockswatch_ny/index.htmStocks futures fell early Tuesday as investors grew cautious ahead of the start of the Federal Reserve's policy meeting.Tue, 29 Apr 2008 10:48:00 EDThttp://money.cnn.com/2008/02/05/news/companies/fosamax/index.htmhttp://money.cnn.com/2008/02/05/news/companies/fosamax/index.htmMerck & Co. bids adieu to its bone disease blockbuster drug on Wednesday, when the patent finally runs out on Fosamax.Wed, 06 Feb 2008 17:57:00 ESThttp://money.cnn.com/2008/02/01/news/companies/drug_wrap/index.htmhttp://money.cnn.com/2008/02/01/news/companies/drug_wrap/index.htmAfter the latest round of mixed earnings from the biggest players in pharma and biotech, companies are hampered by a frustrating dynamic: a product mix that isn't strong enough to match an exodus of blockbusters.Fri, 01 Feb 2008 19:45:00 ESThttp://money.cnn.com/2008/01/29/news/companies/merck/index.htmhttp://money.cnn.com/2008/01/29/news/companies/merck/index.htmMerck & Co. reported a surge in fourth-quarter operating earnings Wednesday that exceeded analysts' estimates, but shares slumped in early trading.Wed, 30 Jan 2008 16:45:00 ESThttp://money.cnn.com/2008/01/28/news/companies/pharma_earnings/index.htmhttp://money.cnn.com/2008/01/28/news/companies/pharma_earnings/index.htmMore big drugmakers are on tap this week to report strong 2007 earnings, but that's because 2006 was an easy act to follow.Mon, 28 Jan 2008 21:29:00 ESThttp://money.cnn.com/2008/01/14/news/companies/merck_simons_risk.fortune/index.htmhttp://money.cnn.com/2008/01/14/news/companies/merck_simons_risk.fortune/index.htmMerck has pulled off a remarkable comeback in the last two years. Now the pharma giant is conjuring medicines with a new scientific swagger, making two particularly risky bets.Mon, 14 Jan 2008 15:20:00 ESThttp://money.cnn.com/2008/01/10/news/companies/healthcare/index.htmhttp://money.cnn.com/2008/01/10/news/companies/healthcare/index.htmAs the market flirts with recession, many of the top performers are healthcare providers, suggesting that the sector could be returning to its old reputation as a safe port in a storm.Thu, 10 Jan 2008 19:23:00 ESThttp://money.cnn.com/2008/01/03/news/companies/new_drugs/index.htmhttp://money.cnn.com/2008/01/03/news/companies/new_drugs/index.htmThe drugmakers Merck and Lilly are the biggest players in Big Pharma's late-stage pipeline, with three possible new blockbusters expected in the coming months.Fri, 04 Jan 2008 16:00:00 ESThttp://money.cnn.com/2008/01/03/news/companies/simons_merck_schizo.fortune/index.htmhttp://money.cnn.com/2008/01/03/news/companies/simons_merck_schizo.fortune/index.htmMerck's $702 million deal with Swiss biotech Addex, announced today, to co-develop a schizophrenia drug may not be a huge deal in the multibillion-dollar world of Big Pharma. But it offers further evidence that the U.S. drug giant is securing its future by essentially outsourcing its research and development to smaller, nimbler firms.Thu, 03 Jan 2008 20:45:00 ESThttp://www.time.com/time/health/article/0,8599,1694147,00.html?xid=feed-cnn-topicshttp://www.time.com/time/health/article/0,8599,1694147,00.html?xid=feed-cnn-topicsThe recall of a routine vaccine for babies due to contamination risks could trigger a shortage and likely will alarm parents, but officials said there is no known health threatThu, 13 Dec 2007 15:40:00 ESThttp://money.cnn.com/2007/12/10/news/companies/mevacor/index.htmhttp://money.cnn.com/2007/12/10/news/companies/mevacor/index.htmThe drugmaker Merck is taking its third swing at trying to get over-the-counter approval for its cholesterol lowering drug Mevacor.Thu, 13 Dec 2007 12:16:00 ESThttp://money.cnn.com/2007/12/11/news/companies/merck/index.htmhttp://money.cnn.com/2007/12/11/news/companies/merck/index.htmThe drugmaker Merck & Co. said Tuesday that it will seek federal approval for two new experimental drugs next year, adding that it's on track to meet its sales targets.Tue, 11 Dec 2007 17:36:00 ESThttp://money.cnn.com/2007/12/04/news/companies/merck/index.htmhttp://money.cnn.com/2007/12/04/news/companies/merck/index.htmMerck failed to excite investors with its financial guidance for 2007 and 2008, causing a temporary stock drop, but analysts were reluctant to condemn the drugmaker.Tue, 04 Dec 2007 17:09:00 ESThttp://money.cnn.com/2007/12/04/markets/markets_nyopen/index.htmhttp://money.cnn.com/2007/12/04/markets/markets_nyopen/index.htmU.S. stocks retreated early Tuesday as investors remained jittery about the nation's economy.Tue, 04 Dec 2007 14:33:00 ESThttp://money.cnn.com/2007/12/04/markets/stockswatch_ny/index.htmhttp://money.cnn.com/2007/12/04/markets/stockswatch_ny/index.htmStocks were poised for a lower open Tuesday as Federal Reserve officials voiced new worries about the economy, drugmaker Merck gave disappointing 2008 guidance, and lawmakers turned their sights on credit card debt as a fresh area of worry.Tue, 04 Dec 2007 13:26:00 ESThttp://money.cnn.com/2007/11/12/news/companies/behind_the_counter/index.htmhttp://money.cnn.com/2007/11/12/news/companies/behind_the_counter/index.htmLed by the emergency contraceptive Plan B, a new class of drugs called "behind-the-counter" is entering the FDA's spotlight.Mon, 19 Nov 2007 21:31:00 ESThttp://money.cnn.com/2007/11/13/news/companies/galvus/index.htmhttp://money.cnn.com/2007/11/13/news/companies/galvus/index.htmNovartis' troubled diabetes drug Galvus, which has been approved by European regulators, might never make it to the U.S. market, an analyst said Tuesday.Tue, 13 Nov 2007 16:53:00 ESThttp://money.cnn.com/2007/11/09/news/companies/merck_vioxx/index.htmhttp://money.cnn.com/2007/11/09/news/companies/merck_vioxx/index.htmMerck & Co. announced Friday that it will pay $4.85 billion to settle as claims by as many as 47,000 groups of plaintiffs over injuries linked to its blockbuster Vioxx painkiller.Fri, 09 Nov 2007 18:29:00 ESThttp://money.cnn.com/2007/10/09/news/companies/rna/index.htmhttp://money.cnn.com/2007/10/09/news/companies/rna/index.htmBiotechs and big pharma are betting billions on an experimental technology that could be a quantum leap for healthcare, or just a big bust.Thu, 11 Oct 2007 19:16:00 EDThttp://money.cnn.com/2007/09/21/news/companies/merck_hiv.ap/index.htmhttp://money.cnn.com/2007/09/21/news/companies/merck_hiv.ap/index.htmA promising experimental vaccine to prevent the AIDS virus has failed in a crucial experiment, with volunteers becoming infected with HIV anyway, leading the drug developer to halt the study.Fri, 21 Sep 2007 09:12:00 EDThttp://money.cnn.com/2007/09/06/news/companies/bc.apfn.vioxxclassaction.ap/index.htmhttp://money.cnn.com/2007/09/06/news/companies/bc.apfn.vioxxclassaction.ap/index.htmIn a major legal victory for Merck & Co. in its massive Vioxx litigation, New Jersey's Supreme Court on Thursday rejected a potential class-action lawsuit that could have cost the drugmaker up to $18 billion.Thu, 06 Sep 2007 09:29:00 EDThttp://money.cnn.com/2007/09/05/news/companies/merck/index.htmhttp://money.cnn.com/2007/09/05/news/companies/merck/index.htmFDA advisors voted unanimously in support of an experimental HIV drug from Merck, according to the company and the government agency.Wed, 05 Sep 2007 08:35:00 EDThttp://money.cnn.com/2007/08/31/news/companies/merck/index.htmhttp://money.cnn.com/2007/08/31/news/companies/merck/index.htmFDA advisers believe that an experimental HIV drug from Merck is safe and effective, based on documents released by the agency.Fri, 31 Aug 2007 08:52:00 EDThttp://money.cnn.com/2007/08/30/markets/spotlight_mrk/index.htmhttp://money.cnn.com/2007/08/30/markets/spotlight_mrk/index.htmMerck has enjoyed a strong comeback since the messy Vioxx blowout nearly three years ago. But you might be surprised by how well Merck has done since it pulled its arthritis drug from the market.Thu, 30 Aug 2007 05:52:00 EDThttp://money.cnn.com/2007/08/20/news/companies/drug_launch/index.htmhttp://money.cnn.com/2007/08/20/news/companies/drug_launch/index.htmThe successful launch of a blockbuster drug depends heavily on Big Pharma's ability to custom-tailor its sales pitch country-by-country, a difficult task in which few drugmakers excel, according to a study from research firm IMS Health.Fri, 24 Aug 2007 07:41:00 EDThttp://money.cnn.com/2007/08/06/news/companies/foot_and_mouth/index.htmhttp://money.cnn.com/2007/08/06/news/companies/foot_and_mouth/index.htmA vaccine laboratory in England that is being investigated for a potential link to a foot-and-mouth outbreak at a nearby farm is owned by vaccine manufacturers Merck and Sanofi-Aventis.Tue, 07 Aug 2007 08:12:00 EDThttp://money.cnn.com/2007/07/23/news/companies/bc.merck.results.reut/index.htmhttp://money.cnn.com/2007/07/23/news/companies/bc.merck.results.reut/index.htmMerck & Co. said Monday that quarterly earnings rose 12 percent on strong demand for its newer vaccines and medicines, and raised its 2007 profit forecast, sending its shares up nearly 8 percent.Mon, 23 Jul 2007 04:25:00 EDThttp://money.cnn.com/2007/07/16/news/companies/big_pharma/index.htmhttp://money.cnn.com/2007/07/16/news/companies/big_pharma/index.htmThe Street is bullish on Big Pharma, and experts believe the launch of new, fast-growing drugs fueled earnings for most of the major U.S. drugmakers in the second quarter.Mon, 16 Jul 2007 06:52:00 EDThttp://money.cnn.com/2007/07/02/news/companies/pharma_biotech/index.htmhttp://money.cnn.com/2007/07/02/news/companies/pharma_biotech/index.htmShares of traditional drug makers left biotechs in the dust in the first half of 2007, a role-reversal of the recent past, when investors favored the fast-growing but risky biotechs over so-called Big Pharma stocks.Tue, 03 Jul 2007 09:46:00 EDThttp://money.cnn.com/2007/06/29/news/companies/merck/index.htmhttp://money.cnn.com/2007/06/29/news/companies/merck/index.htmBiogen Idec's chief financial officer Peter Kellogg is moving over to Merck, where he has been named the new CFO, the companies said on Friday.Fri, 29 Jun 2007 05:52:00 EDThttp://money.cnn.com/2006/12/21/news/companies/topfivedrugs/index.htmhttp://money.cnn.com/2006/12/21/news/companies/topfivedrugs/index.htmAfter a rough couple of years dealing with patent expirations and the often frustrating hunt for new products, drug industry executives would love nothing better than an oracle to predict what products in their labs will become the big blockbuster drugs over the next few years.Thu, 21 Dec 2006 14:48:00 ESThttp://money.cnn.com/2006/12/12/news/companies/merck/index.htmhttp://money.cnn.com/2006/12/12/news/companies/merck/index.htmMerck plans to submit three new drugs to the Food and Drug Administration in 2007 and said it will have four experimental drugs in late-stage testing, the company said Tuesday.Tue, 12 Dec 2006 13:38:00 ESThttp://money.cnn.com/2006/11/08/news/companies/merck/index.htmhttp://money.cnn.com/2006/11/08/news/companies/merck/index.htmDrugmaker Merck & Co. faces a potential $5.58 billion in tax liabilities from U.S. and Canadian authorities related to a number of disputes over accounting for past transactions, the company said in a filing Tuesday.Wed, 08 Nov 2006 07:09:00 ESThttp://money.cnn.com/2006/06/28/news/companies/vioxx/index.htmhttp://money.cnn.com/2006/06/28/news/companies/vioxx/index.htmThe latest lawsuit against Merck over its market-pulled painkiller Vioxx debuts this week in a California courtroom, while the drug giant continues to defend itself in a separate trial in New Jersey.Wed, 28 Jun 2006 16:56:00 EDThttp://money.cnn.com/2006/06/26/news/companies/vioxx/index.htmhttp://money.cnn.com/2006/06/26/news/companies/vioxx/index.htmThe New England Journal of Medicine posted a correction in its current issue, removing its previously published finding that it takes at least 18 months for heart attack risks to increase from use of Vioxx, the anti-arthritis painkiller that Merck pulled from the market.Mon, 26 Jun 2006 17:33:00 EDThttp://money.cnn.com/2006/05/30/news/companies/vioxx/index.htmhttp://money.cnn.com/2006/05/30/news/companies/vioxx/index.htmMerck, the no. 2 drugmaker in America, said on Tuesday that it made a correction to the study that led to the withdrawal of its arthritis painkiller Vioxx, but that it didn't change the results of the study.Tue, 30 May 2006 20:52:00 EDThttp://money.cnn.com/2006/05/19/news/economy/vioxx/index.htmhttp://money.cnn.com/2006/05/19/news/economy/vioxx/index.htmMerck is just weeks away from its next trial over the former blockbuster drug Vioxx, and lawyers from both sides have fresh fodder for the courtroom battle.Fri, 19 May 2006 15:58:00 EDThttp://money.cnn.com/2006/05/11/news/companies/vioxx/index.htmhttp://money.cnn.com/2006/05/11/news/companies/vioxx/index.htmMerck announced that Vioxx patients did not suffer an increased risk of heart attacks from blood clots after they stopped taking the drug, though the company said it would not change its legal strategy regarding the withdrawn painkiller.Thu, 11 May 2006 20:24:00 EDThttp://money.cnn.com/2006/05/09/news/companies/merck/index.htmhttp://money.cnn.com/2006/05/09/news/companies/merck/index.htmMerck & Co., Inc. agreed to buy GlycoFi, Inc. and Abmaxis, both biotechs, to strengthen its pipeline, the drug manufacturer said Tuesday.Tue, 09 May 2006 12:13:00 EDThttp://money.cnn.com/2005/12/09/markets/stockswatch/index.htmhttp://money.cnn.com/2005/12/09/markets/stockswatch/index.htmStocks were looking for direction early Friday, as reports of corporate deals were balanced by disappointing guidance from Intel and higher oil prices.Fri, 09 Dec 2005 10:32:00 ESThttp://money.cnn.com/2005/11/03/news/fortune500/merck_humeston/index.htmhttp://money.cnn.com/2005/11/03/news/fortune500/merck_humeston/index.htmMerck & Co. was found not liable by a New Jersey jury Thursday in the second Vioxx trial -- a key victory for the troubled drugmaker as it faces thousands of other lawsuits over the painkiller.Thu, 03 Nov 2005 15:15:00 ESThttp://money.cnn.com/2005/05/05/news/fortune500/merck/index.htmhttp://money.cnn.com/2005/05/05/news/fortune500/merck/index.htmDrugmaker Merck & Co. -- set back on its heels last year when its Vioxx painkiller was forced off the market -- named company veteran Richard T. Clark as its new CEO and president Thursday, succeeding Raymond Gilmartin, who is retiring next year.Thu, 05 May 2005 12:19:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/2004/11/01/8189593/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2004/11/01/8189593/index.htmListening to Ray Gilmartin, you can't help but be struck by how matter-of-fact and calm the man seems. The 63-year-old Merck chairman and CEO is soft-spoken, quick with a smile, and unfailingly pol...Mon, 01 Nov 2004 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/1995/06/12/203824/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1995/06/12/203824/index.htmHe's a small manufacturer in the Midwest--call him Jack. His company makes inexpensive housewares, about $20 million worth every year. His customers include Wal-Mart, Kmart, and Target, three giant...Mon, 12 Jun 1995 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1995/04/03/224124/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1995/04/03/224124/index.htmNo enterprise can achieve greatness without a superior product or service. Thus have our most successful business leaders--alive or dead, and bound for the Hall of Fame--explored all paths in searc...Mon, 03 Apr 1995 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1988/01/18/70101/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1988/01/18/70101/index.htm^ THINK YOU had a good year? Merck just wrapped up 12 months in which sales are projected to increase over 20% to $5 billion and earnings more than 30% to $900 million. Behind those numbers are som...Mon, 18 Jan 1988 05:01:00 EST